About DSpace Software

Digital Knowledge Repository of Central Drug Research Institute, Lucknow (India) >
Publications of CDRI Scientists >
Medicinal and Process Chemistry >

Please use this identifier to cite or link to this item: http://hdl.handle.net/123456789/579

Title: Substituted quinolinyl chalcones and quinolinyl pyrimidines as a new class of anti-infective agents
Authors: Sharma, Moni
Chaturvedi, Vinita
Manju, Y K
Bhatnagar, Shalini
Srivastava, Kumkum
Puri, S K
Chauhan, P M S
Keywords: Tuberculosis
Malaria
Chalcones
Pyrimidines
Issue Date: 2009
Citation: European Journal of Medicinal Chemistry , 44, 5, 2009, 2081-2091
Abstract: Frequency of tuberculosis and malaria is progressively increasing worldwide. New emerging strain of bacterium and resistance to currently available drugs make this field more conscientious and alarming. In this connection a series of substituted quinolinyl chalcones and substituted quinolinyl pyrimidines were synthesised and evaluated for their in vitro antitubercular activity against Mycobacterium tuberculosis H37RV and antimalarial activity against NF-54 strain of Plasmodium falciparum. A comparison of structure-activity relationship reveals that different physicochemical and structural requirements exist for these two activities. Out of synthesized compounds, compound No. 18, 19 have shown antitubercular activity of MIC 3.12 µg/ml and were non toxic against VERO, MBMDM cell lines and compounds 49, 50, 51 have shown antimalarial activity of MIC 1.0 µg/ml.
URI: http://hdl.handle.net/123456789/579
Appears in Collections:Medicinal and Process Chemistry

Files in This Item:

File Description SizeFormat
chauhanpms-7510-EJMC-44-5-2009-2081-2091.pdf178KbAdobe PDFView/Open

All items in DSpace are protected by copyright, with all rights reserved.

 

DKR - A Collaborative Effort of Documentation & Library Services Division and Information Technology Unit, CDRI, Lucknow
For Suggestions/Observations, Please mail to Suman K Mallik

DSpace Software Copyright © 2002-2005 MIT and Hewlett-Packard - Feedback